Jesper Tranekjær Jørgensen

University of Copenhagen — Denmark

Medicine · Health Sciences

21h-index1.7kcitations76works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(27), Click Chemistry and Applications(24), Medical Imaging Techniques and Applications(19), Monoclonal and Polyclonal Antibodies Research(15), Nanoplatforms for cancer theranostics(13)

Publications76 total

Comparison of Organometallics Towards Electrophilic Aromatic 211At-Astatinations of Tetrazines and Application in Pretargeted Therapy
Nuclear Medicine and Biology·2025Open Access
Head-to-Head Comparison of the <i>in Vivo</i> Performance of Highly Reactive and Polar <sup>18</sup>F-Labeled Tetrazines
Molecular Pharmaceutics·2025Open Access
An <sup>211</sup>At-labeled Tetrazine for Pretargeted Therapy
Journal of Medicinal Chemistry·2025· 3 cited
Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin – A feasibility study using positron emission tomography and [64Cu]Cu-DOTATATE
Nuclear Medicine and Biology·2024Open Access
Development of BODIPY-Tetrazines as Pretargeted Bimodal Fluorescent-Radioactive Tracers
Nuclear Medicine and Biology·2023
Development of five Polar and Highly Reactive Tetrazines for Pretargeted Imaging
Nuclear Medicine and Biology·2023
Targeted imaging of uPAR expression in vivo with cyclic AE105 variants
Scientific Reports·2023· 6 citedOpen Access
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
iScience·2023· 15 citedOpen Access
Neoadjuvant Gold Nanoshell-Based Photothermal Therapy Combined with Liposomal Doxorubicin in a Mouse Model of Colorectal Cancer
International Journal of Nanomedicine·2023· 15 citedOpen Access
An alpaca-derived nanobody recognizes a unique conserved epitope and retains potent activity against the SARS-CoV-2 omicron variant
2022Open Access
Synthesis and radiolabeling of a polar [<sup>125</sup>I]I‐1,2,4,5‐tetrazine
Journal of Labelled Compounds and Radiopharmaceuticals·2022· 4 citedOpen Access
Synthesis and in vivo evaluation of [11C]tucatinib for HER2-targeted PET imaging
Bioorganic & Medicinal Chemistry Letters·2022· 7 citedOpen Access
Bioorthogonal Click of Colloidal Gold Nanoparticles to Antibodies In vivo
Chemistry - A European Journal·2022· 11 citedOpen Access
Combination of [177Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model
Pharmaceutics·2022· 8 citedOpen Access
Extracorporeal clearing traps based on tetrazine ligation for pretargeted therapy and diagnostics
Nuclear Medicine and Biology·2022
Development of aliphatic 18F-labeled tetrazines suitable for pretargeted PET imaging
Nuclear Medicine and Biology·2022
Theranostic tetrazines: radiosynthesis and evaluation of aromatic 18F/211At pair highly reactive tetrazines for pretargeted bioorthogonal PET imaging and targeted alpha-therapy
Nuclear Medicine and Biology·2022
Tetrazine ligation based pretargeting strategy for core-labeled polymeric micelles
Nuclear Medicine and Biology·2022
Development of 11C-Tucatinib as a potential HER2-targeting PET radiotracer
Nuclear Medicine and Biology·2022
Binding of [64Cu]DOTATATE beyond the BBB
Nuclear Medicine and Biology·2022
page 1 of 4Next →

Frequent Co-authors

Andreas Kjær(42), Matthias M. Herth(18), Vladimir Shalgunov(15), Kamilla Nørregaard(13), Lars Hvass(11), Marina Simón(11), Umberto Maria Battisti(10), Anders E. Hansen(8), Patricia E. Edem(7), Christian B. M. Poulie(7), Hannes Mikula(7), Klas Bratteby(6), Jesper L. Kristensen(6), Dennis Svatunek(5), Marc S. Robillard(5), Thomas L. Andresen(5), Mette Munk Jensen(4), E. Johanna L. Stéen(4), Jacob Madsen(4), Raffaella Rossin(4)